ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,628Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 917

$656K Total Retail Price of All Prescriptions

Rank: 54 out of 917

381 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

25% of this provider’s 381 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 381 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,702 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
FUROSEMIDE 497 422 1 7
SIMVASTATIN 477 421 2 2
LEVOTHYROXINE SODIUM 411 364 3 3
WARFARIN SODIUM 395 389 4 10
LISINOPRIL 390 358 5 1
POTASSIUM CHLORIDE 358 330 6 16
HYDROCODONE-ACETAMINOPHEN 310 284 S3 7 6
METOPROLOL TARTRATE 304 270 8 11
CITALOPRAM HBR 276 229 9 15
RISPERIDONE 274 253 10 51
OXYCODONE HCL 248 112 S2 11 27
METFORMIN HCL 218 180 12 8
OMEPRAZOLE 209 157 13 4
MIRTAZAPINE 196 195 14 39
GABAPENTIN 196 129 14 17
QUETIAPINE FUMARATE 175 165 16 52
DONEPEZIL HCL 168 158 17 32
RANITIDINE HCL 161 131 18 29
AMLODIPINE BESYLATE 161 145 18 5
MORPHINE SULFATE ER 148 101 S2 20 48
NOVOLOG 145 128 21 98
CARVEDILOL 143 142 22 33
DIVALPROEX SODIUM 140 123 23 75
LACTULOSE 134 126 24 133
ALENDRONATE SODIUM 133 116 25 23
CLOPIDOGREL 114 110 26 50
SPIRONOLACTONE 113 100 27 55
TRAZODONE HCL 111 94 28 22
LANTUS 111 91 28 37
VENLAFAXINE HCL ER 111 100 28 78
TRAMADOL HCL 108 107 31 28
NAMENDA 106 106 32 43
SERTRALINE HCL 89 85 33 24
OXYCODONE-ACETAMINOPHEN 88 65 S2 34 46
OLANZAPINE 88 88 34 103
GLIPIZIDE 87 86 36 40
SEROQUEL 83 79 37 119
METOPROLOL SUCCINATE 83 83 37 18
BACLOFEN 76 58 39 82
SPIRIVA 73 70 40 45
ALLOPURINOL 70 70 41 31
OXYBUTYNIN CHLORIDE 69 55 42 76
ATORVASTATIN CALCIUM 67 65 43 14
HYDRALAZINE HCL 62 62 44 90
IBUPROFEN 61 25 45 97
ATENOLOL 61 61 45 12
CYMBALTA 61 59 45 56
PHENYTOIN SODIUM EXTENDED 60 54 48 155
FENTANYL 57 57 S2 49 58
PEN NEEDLE 57 18 49 99
HYDROCHLOROTHIAZIDE 56 40 51 9
TAMSULOSIN HCL 55 49 52 25
PLAVIX 55 50 52 84
JANTOVEN 54 50 54 178
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 46 54 116
CEPHALEXIN 53 47 56 105
OXYCONTIN 52 41 S2 57 100
DIGOXIN 51 51 58 41
ADVAIR DISKUS 51 47 58 47
LIDODERM 50 48 60 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.